HS
CGON icon

HighVista Strategies’s CG Oncology CGON Stock Holding History

HighVista Strategies’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.35M Sell
19,914
-9,411
-32% -$533K 0.37% 87
2025
Q4 		$1.22M Buy
29,325
+3,285
+13% +$136K 0.31% 87
2025
Q3 		$1.05M Buy
26,040
+15,712
+152% +$457K 0.26% 118
2025
Q2 		$269K Sell
10,328
-11,977
-54% -$289K 0.1% 139
2025
Q1 		$546K Hold
22,305
– – 0.21% 124
2024
Q4 		$640K Buy
22,305
+6,571
+42% +$225K 0.24% 121
2024
Q3 		$594K Buy
+15,734
New +$552K 0.2% 113

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM